RxDoctor Payments DataLook up a doctor →

Brandon Hardesty, MD

Hematology · Indianapolis, INNPI 1952581027

Payments from drug & device makers

$559,998in general payments, 2019–2025

Across 138 payments — averaging $4057.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$360K
  • AstraZeneca$47K
  • Pfizer$44K
  • Shire North American Group Inc$35K
  • Biomarin Pharmaceutical Inc.$18K
  • Global Blood Therapeutics, Inc.$16K
  • plus $40K from 9 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few hematology providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$18,388,341
Medicare patients
145
Services billed
6,523,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →